Clinical trial
Randomized, Placebo-controlled, Double-Blind, Parallel Design, Phase 3 Study to Assess the Safety and Efficacy of Udenafil Tablets in Male Subjects With Erectile Dysfunction
NCT01037218 is registered in ClinicalTrials.gov with Warner Chilcott as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Placebo-controlled, Double-Blind, Parallel Design, Phase 3 Study to Assess the Safety and Efficacy of Udenafil Tablets in Male Subjects With Erectile Dysfunction
- Lead sponsor
- Warner Chilcott
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 30, 2009
- Completion date
- April 30, 2010
- Enrollment
- 601 (actual)
- Sites
- 40
Conditions
As the registry lists them; a condition with its own page is linked.